106 related articles for article (PubMed ID: 1606625)
1. Changes in the cytoskeleton pattern of tumor cells by cisplatin in vitro.
Köpf-Maier P; Mühlhausen SK
Chem Biol Interact; 1992 May; 82(3):295-316. PubMed ID: 1606625
[TBL] [Abstract][Full Text] [Related]
2. The cytoskeleton as a subcellular target of the antineoplastic drug lonidamine.
Malorni W; Meschini S; Matarrese P; Arancia G
Anticancer Res; 1992; 12(6B):2037-45. PubMed ID: 1295447
[TBL] [Abstract][Full Text] [Related]
3. Cytoskeletal and nuclear alterations in human lung tumor cells: a confocal microscope study.
Manelli-Oliveira R; Machado-Santelli GM
Histochem Cell Biol; 2001 May; 115(5):403-11. PubMed ID: 11449888
[TBL] [Abstract][Full Text] [Related]
4. On the relation between distinct components of the cytoskeleton: an epitope shared by intermediate filaments, microfilaments and cytoplasmic foci.
Turner JR; Tartakoff AM
Eur J Cell Biol; 1990 Apr; 51(2):259-64. PubMed ID: 1693574
[TBL] [Abstract][Full Text] [Related]
5. A rat monoclonal antibody reacting specifically with the tyrosylated form of alpha-tubulin. II. Effects on cell movement, organization of microtubules, and intermediate filaments, and arrangement of Golgi elements.
Wehland J; Willingham MC
J Cell Biol; 1983 Nov; 97(5 Pt 1):1476-90. PubMed ID: 6685128
[TBL] [Abstract][Full Text] [Related]
6. Expression of interleukin 2 receptors on human carcinoma cell lines and tumor growth inhibition by interleukin 2.
Yasumura S; Lin WC; Weidmann E; Hebda P; Whiteside TL
Int J Cancer; 1994 Oct; 59(2):225-34. PubMed ID: 7523315
[TBL] [Abstract][Full Text] [Related]
7. Immunofluorescence evidence for cytoskeletal rearrangement accompanying pigment redistribution in goldfish xanthophores.
Walker GR; Taylor JD; Tchen TT
Cell Motil Cytoskeleton; 1989; 14(4):458-68. PubMed ID: 2560413
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts.
Fan Z; Baselga J; Masui H; Mendelsohn J
Cancer Res; 1993 Oct; 53(19):4637-42. PubMed ID: 8402640
[TBL] [Abstract][Full Text] [Related]
9. PKC mediates 12(S)-HETE-induced cytoskeletal rearrangement in B16a melanoma cells.
Timar J; Tang D; Bazaz R; Haddad MM; Kimler VA; Taylor JD; Honn KV
Cell Motil Cytoskeleton; 1993; 26(1):49-65. PubMed ID: 8221907
[TBL] [Abstract][Full Text] [Related]
10. Cytoskeletal changes during cellular response of the A549 lung cancer cells to continuous cisplatin treatment.
Szczepański MA; Grzanka A; Litwiniec A; Gackowska L; Kubiszewska I; Grzanka D
Cell Biol Int; 2010 Jan; 34(2):197-211. PubMed ID: 19947931
[TBL] [Abstract][Full Text] [Related]
11. Alterations in microtubules, intermediate filaments, and microfilaments induced by microcystin-LR in cultured cells.
Wickstrom ML; Khan SA; Haschek WM; Wyman JF; Eriksson JE; Schaeffer DJ; Beasley VR
Toxicol Pathol; 1995; 23(3):326-37. PubMed ID: 7659955
[TBL] [Abstract][Full Text] [Related]
12. FK317, a novel substituted dihydrobenzoxazine, exhibits potent antitumor activity against human tumor xenografts in nude mice.
Naoe Y; Inami M; Matsumoto S; Takagaki S; Fujiwara T; Yamazaki S; Kawamura I; Nishigaki F; Tsujimoto S; Manda T; Shimomura K
Jpn J Cancer Res; 1998 Dec; 89(12):1306-17. PubMed ID: 10081492
[TBL] [Abstract][Full Text] [Related]
13. A radiolabeled monoclonal antibody binding assay for cytoskeletal tubulin in cultured cells.
Ball RL; Carney DH; Albrecht T; Asai DJ; Thompson WC
J Cell Biol; 1986 Sep; 103(3):1033-41. PubMed ID: 3528166
[TBL] [Abstract][Full Text] [Related]
14. Changes in immunocytochemical detectability of proteasome epitopes depending on cell growth and fixation conditions of lung cancer cell lines.
Machiels BM; Henfling ME; Broers JL; Hendil KB; Ramaekers FC
Eur J Cell Biol; 1995 Mar; 66(3):282-92. PubMed ID: 7539747
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo interaction between cisplatin and topotecan in ovarian carcinoma systems.
Romanelli S; Perego P; Pratesi G; Carenini N; Tortoreto M; Zunino F
Cancer Chemother Pharmacol; 1998; 41(5):385-90. PubMed ID: 9523734
[TBL] [Abstract][Full Text] [Related]
16. The cytoskeleton of human myometrial cells.
Yu JT; López Bernal A
J Reprod Fertil; 1998 Jan; 112(1):185-98. PubMed ID: 9538344
[TBL] [Abstract][Full Text] [Related]
17. Identification of cytoskeletal structures in hormone producing lung cancer cell cultures.
Broers JL; Gropp C; Bepler G; Rot MK; Beck J; Schaart G; Vooijs GP; Ramaekers FC
Acta Histochem Suppl; 1987; 34():57-75. PubMed ID: 2437618
[TBL] [Abstract][Full Text] [Related]
18. Human gingival fibroblast cytoskeleton is a target for volatile smoke components.
Rota MT; Poggi P; Boratto R
J Periodontol; 2001 Jun; 72(6):709-13. PubMed ID: 11453231
[TBL] [Abstract][Full Text] [Related]
19. The effects of taxol on the organization of the cytoskeleton in cultured ovarian granulosa cells.
Herman B; Langevin MA; Albertini DF
Eur J Cell Biol; 1983 Jul; 31(1):34-45. PubMed ID: 6137363
[TBL] [Abstract][Full Text] [Related]
20. Post-translational modification of microtubules is a component of synergic alterations of cytoskeleton leading to formation of cytoplasmic processes in fibroblasts.
Tint IS; Bershadsky AD; Gelfand IM; Vasiliev JM
Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6318-22. PubMed ID: 2068111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
